Silverstein MJ.Duetal carcinoma in sltu of the breast:The treatment controversy.The Breast,2003,12(SI):8Melvin JS. Ductal carcinoma in situ of the breast:The treatment cont roversy[J]. Breast,2003,12(1) :8.Ducta
Ductal carcinoma in situ of the breast: a surgeon's disease. Ann Surg Oncol. 1999;6:802- 810.Silverstein M.J. Ductal carcinoma in situ of the breast: a surgeon's dis- ease. Ann Surg Oncol, 1999, 6: 802- 810.Silverstein MJ. Ductal carcinoma in situ of the breast: A sur- geon'...
ductal carcinoma in situ (DCIS); noninvasive breast cancer Abstract: Ductal carcinoma in situ (DCIS) represents a broad biologic spectrum of disease with a wide range of treatment approaches. A lack of clear and universally accepted treatment criteria has resulted in a diverse range of confusing ...
Invasive ductal carcinoma (IDC), the most common type of breast cancer in the U.S., starts in your milk ducts and spreads to nearby tissue. Like IDC, ductal carcinoma in situ (DCIS) starts in your milk ducts, but it does not spread outside the duct walls. Treatment for IDC and DCIS...
Ductal carcinoma in situ(DCIS)– This occurs when cancer cells fill the ducts but haven't spread through the walls into fatty tissue. Nearly all women diagnosed at this early stage can be cured. Without treatment, about 20% of DCIS cases will lead to invasive breast cancer within 10 years...
For the best product experience, we recommend you upgrade to a newer version of IE or use a different browser: Firefox or Chrome. For additional information please see the ScienceDirect Blog page. Close Journals Books Shopping cart Sign in HelpPurchase Help Direct export Export file ...
Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia The spectrum of genomic alterations in ductal carcinoma in situ (DCIS) is relatively unexplored, but is likely to provide useful insights into its biology, its progression to invasive carcinoma and the risk of ...
et al. HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. Cancer 118, 4354–4362 (2012). Article CAS Google Scholar Antonarelli, G. et al. Therapeutic cancer vaccines revamping: technology advancements and pitfalls. Ann. Oncol. 32, 1537...
2008. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann. Surg. Oncol. 15:235-243. Epub 2007 Nov 7.Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ. Clinical outcome after selective treatment of patients diagnosed ...
To understand the molecular alterations driving the progression of ductal carcinoma in situ (DCIS), we compared patients with pure DCIS and patients with DCIS and synchronous invasive breast cancer (IBC). Twelve patients with extensive pure DCIS were included as a representation of indolent lesions ...